as of 11-13-2026 3:11pm EST
SkinHealth Systems Inc is a world-wide medical aesthetics company delivering an integrated ecosystem of clinically validated solutions designed to help consumers achieve superior skin health and support the success of providers. Its brands are Hydrafacial and SkinStylus.
| Founded: | 1997 | Country: | United States |
| Employees: | N/A | City: | LONG BEACH |
| Market Cap: | 102.4M | IPO Year: | 2020 |
| Target Price: | $14.50 | AVG Volume (30 days): | 69.0K |
| Analyst Decision: | Hold | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.58 | EPS Growth: | 55.56 |
| 52 Week Low/High: | $0.50 - $18.00 | Next Earning Date: | 11-05-2026 |
| Revenue: | $300,790,000 | Revenue Growth: | -10.02% |
| Revenue Growth (this year): | -5.19% | Revenue Growth (next year): | 1.30% |
| P/E Ratio: | -10.20 | Index: | N/A |
| Free Cash Flow: | 37.2M | FCF Growth: | -41.09% |
SEC 8-K filings with transcript text
Nov 5, 2026 · 100% conf.
1D
+13.55%
$12.55
Act: +51.69%
5D
+14.29%
$12.63
20D
+5.90%
$11.70
2 ex991-2026q3xearnings.htm
Document
Exhibit 99.1
SkinHealth Systems Reports Third Quarter 2026 Financial Results
Long Beach, Calif., November 5, 2026 – SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial®, today announced financial results for the third quarter ended September 30, 2026 (“Q3 2026”).
“Our third quarter results reflect encouraging progress in strengthening our business. Revenue trends improved, consumables returned to growth, and we delivered healthy adjusted EBITDA performance. While we have more work ahead, these results give us greater confidence that the actions we are taking are moving the business in the right direction,” said Pedro Malha, President and Chief Executive Officer of SkinHealth Systems.
“We advanced each of our strategic priorities, strengthening commercial execution in the core Hydrafacial franchise, introducing clinically differentiated innovations designed to increase the value and productivity of our installed base, including our new HydraClearTM Treatment Booster, and expanding our portfolio with the launch of SkinStylusTM across six European markets. We also retired our 2026 debt as planned. We have a strong global brand, a substantial installed base and a more efficient operating model. Our focus now is on translating those advantages into sustainable growth through disciplined execution.”
Key Operational and Business Metrics
Three Months Ended September 30,
Nine Months Ended September 30,
Unaudited ($ in millions) (1)
2026
2025
2026
2025
Delivery Systems net sales
$
18.8
$
20.8
$
55.6
$
63.4
Consumables net sales
50.4
49.8
150.6
155.0
Total net sales
$
69.2
$
70.7
$
206.2
$
218.4
Gross profit
$
47.1
$
45.6
$
140.9
$
143.3
Gross margin
68.2
%
64.6
%
68.3
%
65.6
%
Adjusted gross profit(2)
$
49.7
$
48.1
$
148.3
$
149.6
Adjusted gross margin(2)
71.8
%
68.0
%
71.9
%
68.5
%
Operating expenses
$
42.2
$
51.9
$
134.2
$
164.3
Adjusted operating expenses(2)
$
36.3
$
39.1
$
109.4
$
119.5
Net loss
$
(0.9)
$
(11.0)
$
(10.2)
$
(1.4)
Net loss margin
(1.3)
%
(15.6)
%
(4.9)
%
(0.6)
%
Adjusted EBITDA(2)
$
13.4
$
8.9
$
38.9
$
30.1
Adjusted EBITDA margin(2)
19.3
%
12.6
%
18.9
%
13.8
%
Three Months Ended September 30,
Nine Months Ended September 30,
Unaudited
2026
2025
2026
2025
Total delivery systems sold
798
875
2,314
2,694
Active install base(3)
37,342
35,409
37,342
35,409
(1) Amounts may not sum due to rounding.
(2) See "Non-GAAP Financial Measures" below.
(3) Estimated number of delivery systems owned by providers that have purchased consumables in the trailing twelve-month period.
1
Third Quarter Financial Highlights
•Net sales were $69.2 million for the third quarter of 2026, a decrease of (2.1)%, compared to the prior year period ("Q3 2025"), due to lower delivery systems net sales. The Company placed 798 delivery systems during Q3 2026, compared to 875 during Q3 2025.
•Gross margin was 68.2% in Q3 2026, compared to 64.6% in Q3 2025. Adjusted gross margin was 71.8% in Q3 2026, compared to 68.0% in Q3 2025. The improvement in gross margin and adjusted gross margin was primarily due to higher product costs in the prior year related to trade-in Delivery Systems sell through, as well as tariff related recoveries, and lower inventory charges in 2026.
•Operating expenses were $42.2 million in Q3 2026, compared to $51.9 million in Q3 2025. The improvement in operating expenses was primarily due to lower personnel-related expenses, amortization expense, and professional fees. Adjusted operating expenses were $36.3 million in Q3 2026, compared to $39.1 million in Q3 2025. The improvement in adjusted operating expenses was primarily due to lower personnel-related expenses and professional fees.
•Net loss was $(0.9) million in Q3 2026, compared to net loss of $(11.0) million in Q3 2025. The change compared to the prior year was primarily due to lower operational spend and higher gross margin.
•Adjusted EBITDA was $13.4 million in Q3 2026, compared to $8.9 million in Q3 2025. The improvement in adjusted EBITDA was primarily due to lower adjusted operational spend and higher adjusted gross margin.
Balance Sheet and Cash Flow Highlights
•Cash, cash equivalents, and restricted cash were approximately $112 million as of September 30, 2026, compared to approximately $233 million as of December 31, 2025. On September 30, 2026, the Company retired the 2026 Notes in accordance with their terms. The Company repaid the remaining outstanding aggregate principal amount of $103.2 million.
•The Company had 6.5 million shares of Class A Common Stock outstanding as of September 30, 2026. On October 14, 2026, the Company effected a 1-for-20 reverse stock split of its Class A Common Stock and a proportionate decrease in the number of issued
Aug 6, 2026 · 100% conf.
1D
-13.06%
$0.67
Act: -13.91%
5D
-10.87%
$0.68
20D
-13.20%
$0.67
SEC.gov | Request Rate Threshold Exceeded
U.S. Securities and Exchange Commission
You’ve Exceeded the SEC’s Traffic Limit
Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.
Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.
The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.
For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.
For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.
Reference ID: 0.e618d017.1786365434.ca25d9f7
More Information
Internet Security Policy
By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.
Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).
To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.
If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.
Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.
Note: We do not offer technical support for developing or debugging scripted downloading processes.
May 7, 2026 · 100% conf.
1D
-10.17%
$0.82
Act: -36.21%
5D
-9.03%
$0.83
Act: -25.62%
20D
-10.70%
$0.81
Act: -33.23%
2 ex991-2026q1xearnings.htm
Document
Exhibit 99.1
SkinHealth Systems Reports First Quarter 2026 Financial Results
Long Beach, Calif., May 7, 2026 – SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2026 (“Q1 2026”).
“First quarter results reflect the strength of the business. We delivered revenue within our guidance range, significantly outperformed on adjusted EBITDA, and continued to expand margins through disciplined execution.
"While the market remains challenging and we are lowering our full-year revenue outlook, the fundamentals are intact. The installed base is growing, the brand is strong, and we are taking direct action to improve execution while continuing to invest in the capabilities and innovation that will drive long-term growth.” said Pedro Malha, President and CEO of SkinHealth Systems.
Key Operational and Business Metrics
Three Months Ended March 31,
Unaudited ($ in millions) (1)
2026
2025
Delivery Systems net sales
$
18.5
$
20.2
Consumables net sales
46.4
49.4
Total net sales
$
64.9
$
69.6
Gross profit
$
44.4
$
48.6
Gross margin
68.5
%
69.8
%
Adjusted gross profit(2)
$
46.9
$
50.0
Adjusted gross margin(2)
72.2
%
71.9
%
Operating expenses
$
46.2
$
60.6
Adjusted operating expenses(2)
$
38.4
$
42.8
Net loss
$
(6.6)
$
(10.1)
Net loss margin
(10.2)
%
(14.5)
%
Adjusted EBITDA(2)
$
8.5
$
7.3
Adjusted EBITDA margin(2)
13.1
%
10.4
%
Three Months Ended March 31,
Unaudited
2026
2025
Total delivery systems sold
746
862
Active install base(3)
36,419
35,014
(1) Amounts may not sum due to rounding.
(2) See "Non-GAAP Financial Measures" below.
(3) Estimated number of delivery systems owned by providers that have purchased consumables in the trailing twelve-month period.
1
First Quarter Financial Highlights
•Net sales were $64.9 million for the first quarter of 2026, a decrease of (6.7)%, compared to the prior year period ("Q1 2025"), due to lower delivery systems and consumables net sales. The Company placed 746 delivery systems during Q1 2026, compared to 862 during Q1 2025.
•Gross margin was 68.5% in Q1 2026, compared to 69.8% in Q1 2025. The decrease in gross margin was primarily due to higher amortization expense. Adjusted gross margin was relatively flat at 72.2% in Q1 2026 compared to 71.9% in Q1 2025.
•Operating expenses were $46.2 million in Q1 2026, compared to $60.6 million in Q1 2025. Adjusted operating expenses were $38.4 million in Q1 2026, compared to $42.8 million in Q1 2025. The improvement in operating expenses and adjusted operating expenses was primarily due to lower personnel-related expenses and lower marketing-related spend.
•Net loss was $(6.6) million in Q1 2026, compared to $(10.1) million in Q1 2025. The change compared to the prior year was primarily due to lower operational spend, partially offset by lower net sales.
•Adjusted EBITDA was $8.5 million in Q1 2026, compared to $7.3 million in Q1 2025. The improvement in adjusted EBITDA was primarily due to lower operational spend, partially offset by lower net sales.
Revised 2026 Financial Guidance
Second Quarter 2026
Net sales
$72 – $77 million
Adjusted EBITDA(1)
$11 – $13 million
Fiscal Year 2026
Net sales
$280 – $295 million
Adjusted EBITDA(1)
$35 – $45 million
(1) See "Non-GAAP Financial Measures" below.
Revised 2026 financial guidance:
•Reflects continued pressure on year over year device sales.
•Presumes no further material deterioration in current general market conditions or other unforeseen circumstances beyond the Company's control, such as foreign currency exchange rates, tariffs, and trade restrictions.
•Excludes any unannounced acquisitions, dispositions or financings.
2
Regional Operational and Business Metrics
Three Months Ended March 31,
Unaudited ($ in millions) (1) (2)
2026
2025
Delivery Systems net sales
Americas
$
12.0
$
13.1
Asia-Pacific (“APAC”)
2.1
2.0
Europe, the Middle East and Africa (“EMEA”)
4.4
5.1
Total Delivery Systems net sales
$
18.5
$
20.2
Consumables net sales
Americas
$
32.6
$
33.1
4.5
6.4
9.3
9.9
Total Consumables net sales
$
46.4
$
49.4
Net sales
Americas
$
44.6
$
46.3
6.6
8.3
13.7
15.0
Total net sales
$
64.9
$
69.6
Delivery Systems sold
Americas
438
550
118
98
190
214
Total Delivery Systems sold
746
862
(1) Amounts may not sum due to rounding.
(2) During the second quarter of 2025, the Company transitioned sales in the China market to a distributor partner, and as a result, the Company has discontinued direct sales to customers in China.
Conference Call
SkinHealth Systems will host a conference call on Thursday, May 7, 2026, at 4:30
See how SKIN stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "SKIN The Beauty Health Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.